NCT05635942View on ClinicalTrials.gov

Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

August 30, 2022

Study Completion Date

November 1, 2022

Conditions
Helicobacter Pylori
Interventions
DRUG

optimized quadruple therapy

Association of amoxicillin 3 g/day + Esomeprazole, nitroimidazole and clarithromycin for 14 days

DRUG

standard quadruple therapy

Association of amoxicillin 2 g/day + Esomeprazole, nitroimidazole and clarithromycin for 14 days

Trial Locations (1)

2080

Hepatogastroenterology department of Mahmoud Matri Hospital, Aryanah

All Listed Sponsors
lead

Les Laboratoires des Médicaments Stériles

INDUSTRY

NCT05635942 - Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication | Biotech Hunter | Biotech Hunter